By Dr Kate Patterson

Journal articles

Patterson K; Terrill B; Dorfman BS; Blonder R; Yarden A, 2022, 'Molecular animations in genomics education: designing for whom?', Trends in Genetics, 38, pp. 517 - 520, http://dx.doi.org/10.1016/j.tig.2022.03.003

Dorfman BS; Terrill B; Patterson K; Yarden A; Blonder R, 2019, 'Teachers personalize videos and animations of biochemical processes: results from a professional development workshop', Chemistry Education Research and Practice, 20, pp. 772 - 786, http://dx.doi.org/10.1039/c9rp00057g

Burnett DL; Langley DB; Schofield P; Hermes JR; Chan TD; Jackson J; Bourne K; Reed JH; Patterson K; Porebski BT; Brink R; Christ D; Goodnow CC, 2018, 'Germinal center antibody mutation trajectories are determined by rapid self/foreign discrimination', Science, 360, pp. 223 - 226, http://dx.doi.org/10.1126/science.aao3859

Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ, 2013, 'Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer', Oncogene, 32, pp. 2891 - 2899, http://dx.doi.org/10.1038/onc.2012.300

Valdes-Mora F; Song JZ; Statham AL; Strbenac D; Robinson MD; Nair SS; Patterson K; Tremethick DJ; Stirzaker C; Clark SJ, 2012, 'Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer', Genome Research, 22, pp. 307 - 321, http://dx.doi.org/10.1101/gr.118919.110

Gloss B; Patterson K; Barton CA; Gonzalez M; Scurry JP; Hacker NF; Sutherland RL; O''brien P; Clark SJ, 2012, 'Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers', Cancer Letters, 318, pp. 76 - 85, http://dx.doi.org/10.1016/j.canlet.2011.12.003

Patterson K; Molloy L; Qu W; Clark S, 2011, 'DNA methylation: bisulphite modification and analysis.', Journal of visualized experiments : JoVE

Patterson K; Molloy L; Qu W; Clark S, 2011, 'DNA methylation: Bisulphite modification and analysis', Journal of Visualized Experiments, http://dx.doi.org/10.3791/3170

Patterson K; Molloy L; Qu W; Clark SJ, 2011, 'DNA methylation: Bisulphite modification and analysis', Journal of Visualized Experiments, pp. e3170, http://dx.doi.org/10.3791/3170

Devaney J; Stirzaker C; Qu W; Song JZ; Statham AL; Patterson K; Horvath LG; Tabor B; Coolen MW; Hulf T; Kench JG; Henshall SM; Pe benito R; Haynes AM; Mayor R; Peinado M; Sutherland RL; Clark SJ, 2011, 'Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers', Cancer Epidemiology Biomarkers and Prevention, 20, pp. 148 - 159, http://dx.doi.org/10.1158/1055-9965.EPI-10-0719

Wang L; Chen H; Liu F; Madigan MC; Power C; Hao J; Patterson K; Pourgholami MH; O Brien P; Perkins A; Li Y, 2011, 'Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer', Cancer Letters, 300, pp. 122 - 133, http://dx.doi.org/10.1016/j.canlet.2010.09.013

Patterson K; Brummer T; Daly RJ; O Brien P, 2010, 'DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs', Biochimica et Biophysica ACTA, 1803, pp. 1003 - 1012, http://dx.doi.org/10.1016/j.bbamcr.2010.03.014

Patterson K; Brummer T; O Brien P; Daly RJ, 2009, 'Dual-specificity phosphatases: Critical regulators with diverse cellular targets', Biochemical Journal, 418, pp. 475 - 489

Wang LL; Madigan MC; Chen H; Liu F; Patterson K; Beretov J; O Brien P; Li Y, 2009, 'Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients', Gynecologic Oncology, 114, pp. 265 - 272

Knibb J; Woollams A; Hodges JR; Patterson K, 2009, 'Making sense of progressive non-fluent aphasia: An analysis of conversational speech', Brain, 132, pp. 2734 - 2746

O'Brien PM; Davies MJ; Scurry JP; Smith AN; Barton CA; Henderson MJ; Saunders DN; Gloss BS; Patterson KI; Clancy JL; Heinzelmann-Schwarz VA; Murali R; Scolyer RA; Zeng Y; Williams ED; Scurr L; DeFazio A; Quinn DI; Watts CKW; Hacker NF; Henshall SM; Sutherland RL, 2008, 'The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (British Journal of Cancer (2008) 98, (1085-1093) DOI: 10.1038/sj.bjc.6604281))', British Journal of Cancer, 98, pp. 1880, http://dx.doi.org/10.1038/sj.bjc.6604419

O Brien P; Davies M; Scurry JP; Smith A; Barton CA; Henderson M; Saunders DN; Gloss B; Patterson K; Clancy JL; Heinzelmann-Schwarz V; Scolyer R; Zeng Y; Williams E; Scurr LL; Defazio A; Quinn DI; Watts CK; Hacker NF; Henshall SM; Sutherland RL, 2008, 'The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro', British Journal of Cancer, 98, pp. 1085 - 1093, http://dx.doi.org/10.1038/sj.bjc.6604281

Back to profile page